Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Kiren Khanduga; Alicia Levey, Ph.D.
Pionyr Immunotherapeutics
PAO-06-022-CL-04Jun 06, 2022
M&A
Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics
Gilead Sciences
PR-M06-20-NI-028Jun 23, 2020